Heart disease remains one of the leading causes of death—but breakthroughs in science are rewriting the narrative. Join us as Dr. Kevin Alexander, a Assistant Professor of Cardiovascular Medicine at Stanford University, takes us on a journey through the frontlines of heart health innovation. Discover transthyretin amyloid cardiomyopathy (ATTR-CM), a condition disproportionately affecting older African Americans, and learn how cutting-edge treatments are offering new hope. Through a discussion on risk factors, symptoms, and barriers to care, Dr. Alexander highlights the actionable steps to improve awareness and access in underserved communities.

Ver todos los episodios